CEA is an Independent Prognostic Indicator that is Associated with Reduced Survival and Liver Metastases in SCLC

Cell Biochemistry and Biophysics

Volumn 59, Issue 2, 2011, Pages 113-119

  Yang, Xueqin ^a   Wang, Dong ^a   Yang, Zhenzhou ^a   Qing, Yi ^a   Zhang, Zhimin ^a   Wang, Ge ^a   Yang, Zhixiang ^a   Wang, Zhengbo ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

CEA; Prognosis; SCLC

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; TUMOR MARKER;

AGED; ARTICLE; BLOOD; CANCER STAGING; FEMALE; HUMAN; LIVER TUMOR; LUNG SMALL CELL CANCER; MALE; METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; SURVIVAL RATE;

AGED; CARCINOEMBRYONIC ANTIGEN; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SMALL CELL LUNG CARCINOMA; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 79951856424     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-010-9121-0     Document Type: Article

References (25)

1. Jemal, A., Tiwari, R. C., Murray, T., Ghafoor, A., Samuels, A., Ward, E., et al. (2004). Cancer statistics, 2004. CA: A Cancer Journal for Clinicians, 54, 8-29.
2. Govindan, R., Page, N., Morgensztern, D., Read, W., Tierney, R., Vlahiotis, A., et al. (2006). Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: Analysis of the surveillance, epidemiologic, and end results database. Journal of Clinical Oncology, 24, 4539-4544.
3. Micke, P., Faldum, A., Metz, T., Beeh, K. M., Bittinger, F., Hengstler, J. G., et al. (2002). Staging small cell lung cancer: Veterans administration lung study group versus international association for the study of lung cancer-what limits limited disease? Lung Cancer, 37, 271-276.
4. Azad, A., Chionh, F., Scott, A. M., Lee, S. T., Berlangieri, S. U., White, S., et al. (2010). High impact of (18)f-fdg-pet on management and prognostic stratification of newly diagnosed small cell lung cancer. Molecular Imaging and Biology, 12, 443-451.
5. Osterlind, K., Hansen, H. H., Hansen, M., Dombernowsky, P., & Andersen, P. K. (1986). Long-term disease-free survival in small-cell carcinoma of the lung: A study of clinical determinants. Journal of Clinical Oncology, 4, 1307-1313.
6. Seifter, E. J., & Ihde, D. C. (1988). Therapy of small cell lung cancer: A perspective on two decades of clinical research. Seminars in Oncology, 15, 278-299.
7. Bremnes, R. M., Sundstrom, S., Aasebo, U., Kaasa, S., Hatlevoll, R., & Aamdal, S. (2003). The value of prognostic factors in small cell lung cancer: Results from a randomised multicenter study with minimum 5 year follow-up. Lung Cancer, 39, 303-313.
8. Hatzakis, K. D., Froudarakis, M. E., Bouros, D., Tzanakis, N., Karkavitsas, N., & Siafakas, N. M. (2002). Prognostic value of serum tumor markers in patients with lung cancer. Respiration, 69, 25-29.
9. Pujol, J. L., Quantin, X., Jacot, W., Boher, J. M., Grenier, J., & Lamy, P. J. (2003). Neuroendocrine and cytokeratin serum markers as prognostic determinants of small cell lung cancer. Lung Cancer, 39, 131-138.
10. Hammarstrom, S. (1999). The carcinoembryonic antigen (CEA) family: Structures, suggested functions and expression in normal and malignant tissues. Seminars in Cancer Biology, 9, 67-81.
11. Arrieta, O., Saavedra-Perez, D., Kuri, R., Aviles-Salas, A., Martinez, L., Mendoza-Posada, D., et al. (2009). Brain metastasis development and poor survival associated with carcinoembryonic antigen (CEA) level in advanced non-small cell lung cancer: A prospective analysis. BMC Cancer, 9, 119.
12. Tomita, M., Shimizu, T., Hara, M., Ayabe, T., & Onitsuka, T. (2009). Serum carcinoembryonic antigen level in non-small-cell lung cancer patients with preoperative normal serum level. General Thoracic and Cardiovascular Surgery, 57, 303-306.
13. Molina, R., Auge, J. M., Escudero, J. M., Marrades, R., Vinolas, N., Carcereny, E., et al. (2008). Mucins CA125, CA19. 9, CA15. 3 and TAG-72. 3 as tumor markers in patients with lung cancer: Comparison with CYFRA 21-1, CEA, ACC and NSE. Tumour Biology, 29, 371-380.
14. Kim, J. Y., Kim, N. K., Sohn, S. K., Kim, Y. W., Kim, K. J., Hur, H., et al. (2009). Prognostic value of postoperative CEA clearance in rectal cancer patients with high preoperative CEA levels. Annals of Surgical Oncology, 16, 2771-2778.
15. Park, I. J., Choi, G. S., Lim, K. H., Kang, B. M., & Jun, S. H. (2009). Serum carcinoembryonic antigen monitoring after curative resection for colorectal cancer: Clinical significance of the preoperative level. Annals of Surgical Oncology, 16, 3087-3093.
16. Watanabe, K., Nagai, K., Kobayashi, A., Sugito, M., & Saito, N. (2009). Factors influencing survival after complete resection of pulmonary metastases from colorectal cancer. British Journal of Surgery, 96, 1058-1065.
17. Vallieres, E., Shepherd, F. A., Crowley, J., van Houtte, P., Postmus, P. E., Carney, D., et al. (2009). The IASLC lung cancer staging project: Proposals regarding the relevance of tnm in the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the tnm classification for lung cancer. Journal of Thoracic Oncology, 4, 1049-1059.
18. Ilantzis, C., DeMarte, L., Screaton, R. A., & Stanners, C. P. (2002). Deregulated expression of the human tumor marker CEA and CEA family member ceacam6 disrupts tissue architecture and blocks colonocyte differentiation. Neoplasia, 4, 151-163.
19. Nittka, S., Bohm, C., Zentgraf, H., & Neumaier, M. (2008). The ceacam1-mediated apoptosis pathway is activated by CEA and triggers dual cleavage of ceacam1. Oncogene, 27, 3721-3728.
20. Kokkonen, N., Ulibarri, I. F., Kauppila, A., Luosujarvi, H., Rivinoja, A., & Pospiech, H. (2007). Hypoxia upregulates carcinoembryonic antigen expression in cancer cells. International Journal of Cancer, 121, 2443-2450.
21. Jessup, J. M., Samara, R., Battle, P., & Laguinge, L. M. (2004). Carcinoembryonic antigen promotes tumor cell survival in liver through an il-10-dependent pathway. Clinical & Experimental Metastasis, 21, 709-717.
22. Zimmer, R., & Thomas, P. (2001). Mutations in the carcinoembryonic antigen gene in colorectal cancer patients: Implications on liver metastasis. Cancer Research, 61, 2822-2826.
23. Giovanella, L., Piantanida, R., Ceriani, L., Bandera, M., Novario, R., & Bianchi, L. (1997). Immunoassay of neuron-specific enolase (NSE) and serum fragments of cytokeratin 19 (cyfra 21. 1) as tumor markers in small cell lung cancer: Clinical evaluation and biological hypothesis. International Journal of Biological Markers, 12, 22-26.
24. Molina, R., Filella, X., & Auge, J. M. (2009). Progrp: A new biomarker for small cell lung cancer. Clinical Biochemistry, 37, 505-511.
25. Sheng, S. L., Huang, G., Yu, B., & Qin, W. X. (2009). Clinical significance and prognostic value of serum dickkopf-1 concentrations in patients with lung cancer. Clinical Chemistry, 55, 1656-1664.